Skin cancer of the head and neck is the most common malignancy of the head and neck region. The face, scalp, ears, and neck -- constantly exposed to ultraviolet radiation -- account for approximately 80% of all skin cancers. While most are basal cell carcinomas with excellent prognosis, a substantial proportion are squamous cell carcinomas or melanomas carrying significant risk of local destruction, lymph node metastasis, and death if not managed expertly. The unique challenge lies at the intersection of oncology and reconstruction: complete excision with clear margins must be paired with reconstruction that preserves facial function and appearance. At THANC Hospital in Chennai, Dr. Vidhyadharan Sivakumar brings this dual expertise -- MCh in Head and Neck Surgery combined with a microsurgery fellowship at Chang Gung Memorial Hospital, Taiwan -- to deliver margin-controlled excision and sophisticated reconstruction for complex head and neck skin cancers.
Understanding Skin Cancer of the Head and Neck
The skin of the head and neck is uniquely vulnerable to cancer. It receives the greatest cumulative ultraviolet radiation exposure of any body region, its thin epidermis offers limited protection, and the complex anatomy of the face, nose, ears, eyelids, and lips means that even small cancers can threaten critical structures.
While India has traditionally been considered a low-incidence country due to the protective effect of melanin, skin cancer is increasingly recognised here, particularly in outdoor workers, farmers, and high-altitude populations. Indian Council of Medical Research data indicates that skin cancer accounts for 1-2% of all cancers in India, but this likely underestimates true incidence. When skin cancer does occur in Indian patients, it tends to present at more advanced stages than in Western populations because patients and physicians may not suspect malignancy in darker skin.
The head and neck region presents particular challenges. Critical structures -- the eyes, nose, ears, lips, and facial nerve -- lie millimetres from the skin surface. Surgical excision must balance oncologic adequacy with functional and aesthetic preservation, requiring a surgeon trained in both head and neck cancer surgery and reconstructive techniques.
Types and Classification
The three major types of head and neck skin cancer differ substantially in their behaviour, prognosis, and treatment requirements:
Basal cell carcinoma (BCC) is the most common skin cancer, accounting for approximately 70-80% of all skin cancers. It arises from the basal cells of the epidermis and is strongly associated with cumulative UV exposure. BCC is locally invasive but very rarely metastasises (less than 0.1%). However, untreated BCC can cause extensive local tissue destruction, particularly on the nose, periorbital region, and ears. Subtypes include nodular (most common), superficial, morpheaform/infiltrative (most aggressive locally), and pigmented BCC.
Squamous cell carcinoma (SCC) is the second most common skin cancer, accounting for approximately 20-25% of cases. It arises from the squamous cells of the epidermis and carries meaningful metastatic potential -- approximately 5-10% of head and neck SCCs metastasise to regional lymph nodes. High-risk features include tumour thickness greater than 6 mm, perineural invasion, poor differentiation, immunosuppression, and location on the ear or lip.
Melanoma accounts for only 2-5% of skin cancers but causes the majority of skin cancer deaths due to its high metastatic potential. Head and neck melanoma represents approximately 20-25% of all melanomas, with the scalp and face being common sites. Prognosis is determined primarily by Breslow thickness, ulceration, and sentinel node status.
| Feature | Basal Cell Carcinoma (BCC) | Squamous Cell Carcinoma (SCC) | Melanoma |
|---|---|---|---|
| Frequency | Most common (~70-80%) | Second most common (~20-25%) | Least common (~2-5%) |
| Typical appearance | Pearly nodule, rolled edges, telangiectasia | Firm red scaly plaque or nodule | Dark pigmented lesion, irregular borders |
| Growth rate | Slow (months to years) | Moderate (weeks to months) | Variable, can be rapid |
| Metastatic potential | Very rare (<0.1%) | Moderate (5-10% for head/neck) | High (stage-dependent) |
| Lymph node involvement | Extremely rare | Yes -- sentinel node biopsy or neck dissection for high-risk | Yes -- sentinel node biopsy standard for >0.8 mm |
| Standard surgical margin | 3-5 mm (or Mohs) | 6-10 mm (or margin-controlled excision) | 1-2 cm depending on thickness |
| Radiation sensitivity | Yes (alternative for elderly/unfit) | Yes (adjuvant for high-risk features) | Limited (adjuvant in selected cases) |
| 5-year survival (localised) | >99% | >90% | 95% (<1 mm), 80% (1-2 mm), 60% (>4 mm) |
Less common head and neck skin cancers include Merkel cell carcinoma (aggressive neuroendocrine tumour requiring wide excision, sentinel node biopsy, and adjuvant radiation), dermatofibrosarcoma protuberans (locally aggressive, requires wide margins), and sebaceous carcinoma (primarily affects the eyelid, associated with Muir-Torre syndrome).
Causes and Risk Factors
Risk factors for head and neck skin cancer include both environmental and patient-specific factors:
- Cumulative ultraviolet radiation exposure -- the dominant risk factor. In India, outdoor workers, farmers, fishermen, and construction workers face elevated risk due to the tropical latitude.
- Fair skin -- lower melanin content increases susceptibility, but skin cancer occurs across all skin types in India.
- Immunosuppression -- organ transplant recipients face 65-250 times the risk of SCC. HIV-positive individuals also face elevated risk.
- Previous radiation therapy -- prior radiation to the head and neck increases secondary skin cancer risk.
- Chronic wounds, scars, and ulcers -- Marjolin's ulcer (SCC arising in a chronic wound or burn scar) is relatively more common in India.
- Xeroderma pigmentosum -- a rare genetic condition with extreme UV sensitivity.
- Arsenic exposure -- endemic in certain Indian groundwater regions, associated with BCC and SCC.
Any new or changing skin lesion on the head or neck that persists beyond 4 weeks warrants specialist evaluation.
Signs and Symptoms
Head and neck skin cancers are often visible to the patient and those around them, yet they are frequently ignored or dismissed. Warning signs by type include:
Basal cell carcinoma: A pearly, translucent, or waxy bump on the face; a flat, flesh-coloured or brownish scar-like lesion; a bleeding or scabbing sore that heals and returns; a pink growth with a raised border and crusted centre.
Squamous cell carcinoma: A firm, red nodule on the face, lip, or ear; a flat lesion with a scaly, crusted surface; a new sore or raised area on an old scar; a rough, scaly patch on the lip that may become an open sore.
Melanoma: A new dark spot or mole, or a change in an existing mole. The ABCDE criteria guide evaluation: Asymmetry, Border irregularity, Colour variation, Diameter greater than 6 mm, and Evolving (changing) appearance.
Advanced skin cancer: A fixed, ulcerated mass; involvement of underlying muscle, cartilage, or bone; facial nerve weakness (indicating perineural invasion); palpable lymph nodes in the neck or parotid region.
Diagnosis at THANC Hospital
At THANC Hospital, Dr. Vidhyadharan employs a systematic diagnostic approach for head and neck skin cancers:
- Clinical examination -- thorough inspection of the lesion with documentation of size, location, borders, depth, fixation to underlying structures, and relationship to adjacent anatomical landmarks (eyelids, nose, ears, lips). Complete skin survey to identify additional lesions. Palpation of parotid and cervical lymph nodes.
- Dermoscopy -- magnified examination of the lesion surface to identify patterns suggesting BCC, SCC, or melanoma, guiding biopsy technique.
- Biopsy -- punch biopsy, incisional biopsy, or excisional biopsy depending on lesion size and location. Histopathological examination with immunohistochemistry determines the tumour type, differentiation, depth of invasion, perineural invasion, and lymphovascular invasion.
- Imaging -- CT scan with contrast for advanced cancers to assess bone invasion (skull, maxilla, mandible), orbital involvement, and lymph node status. MRI for perineural spread assessment and orbital/intracranial extension. PET-CT for staging melanoma and high-risk SCC with suspected distant metastasis.
- Sentinel lymph node biopsy -- for melanoma greater than 0.8 mm Breslow thickness and high-risk SCC. A radiotracer is injected near the tumour, and the sentinel node(s) are identified using a gamma probe, removed, and examined by the pathologist. This procedure guides the decision for formal neck dissection.
- Fine needle aspiration (FNAC) of palpable lymph nodes to confirm or exclude metastasis.
Every case is reviewed at the multidisciplinary tumour board at THANC Hospital, with input from head and neck surgery, dermatology, radiation oncology, medical oncology, and pathology.
How Dr. Vidhyadharan Treats Head and Neck Skin Cancer
Dr. Vidhyadharan's MCh in Head and Neck Surgery from Amrita Institute provides the oncologic foundation, while his microsurgery fellowship at Chang Gung Memorial Hospital, Taiwan provides the reconstructive expertise. For more on reconstruction, read our guide on head and neck reconstruction and free flap surgery.
Margin-Controlled Excision (Mohs-Equivalent Surgery)
Dr. Vidhyadharan performs margin-controlled excision equivalent to Mohs micrographic surgery. The tumour is excised with a planned margin, and the entire circumferential and deep margin is mapped and examined using frozen sections while the patient remains in theatre. If any margin shows residual cancer, additional tissue is excised only from the involved area. This continues until all margins are clear, ensuring complete cancer removal while preserving maximum healthy tissue.
Reconstruction After Excision
The reconstruction method depends on the defect size, location, and the structures involved:
- Primary closure for small defects with sufficient skin laxity.
- Local flaps -- bilobed flaps for nasal defects, cervicofacial flaps for cheek defects, Karapandzic or Abbe flaps for lip reconstruction.
- Skin grafts -- full-thickness or split-thickness grafts for scalp and forehead defects.
- Regional flaps -- pectoralis major or supraclavicular flaps for larger defects.
- Free tissue transfer -- anterolateral thigh, radial forearm, or fibula flap for extensive defects involving bone or through-and-through defects. Dr. Vidhyadharan's Chang Gung fellowship enables these complex microsurgical reconstructions.
Neck Dissection and Sentinel Node Biopsy
For confirmed lymph node metastasis, Dr. Vidhyadharan performs formal neck dissection with parotidectomy when parotid nodes are involved. For clinically node-negative high-risk tumours (melanoma greater than 0.8 mm, high-risk SCC), sentinel lymph node biopsy detects occult metastasis and guides further treatment.
Adjuvant Therapy
Adjuvant radiation is recommended for high-risk SCC (positive margins, perineural invasion, extranodal extension), advanced melanoma, and locally advanced BCC. Immunotherapy and targeted therapy (vismodegib for BCC, BRAF/MEK inhibitors for melanoma) are integrated when appropriate through the THANC Hospital tumour board.
What to Expect: Your Treatment Journey
Dr. Vidhyadharan and the THANC Hospital team guide patients through a structured treatment pathway:
Week 1 -- Evaluation and biopsy: Clinical examination, dermoscopy, biopsy (if not already performed), and imaging as indicated. Previous biopsy slides are reviewed by the THANC Hospital pathologist. Sentinel node biopsy is planned for eligible melanoma and high-risk SCC patients. Results are typically available within 3-5 working days.
Week 2 -- Tumour board and treatment planning: Your case is discussed at the multidisciplinary tumour board. Dr. Vidhyadharan explains the surgical plan -- excision margins, reconstruction options, need for sentinel node biopsy or neck dissection, and potential adjuvant therapy. Patients are shown pre-operative photographs and reconstructive options to set realistic expectations. For a comprehensive understanding of treatment costs, refer to our guide on head and neck cancer treatment cost in India.
Week 2-3 -- Pre-operative preparation: Pre-anaesthesia assessment, blood work, and any additional imaging. Reconstruction planning is finalised, including donor site selection for flap surgery.
Surgery day: Operating time ranges from 1-2 hours for margin-controlled excision with local flap to 6-10 hours for wide excision with free flap reconstruction and neck dissection. General anaesthesia is used for most procedures; small BCC excisions may be performed under local anaesthesia.
Hospital stay: Simple excision with local flap -- day case or 1-2 nights. Excision with skin graft or regional flap -- 3-5 days. Free flap reconstruction -- 7-10 days for flap monitoring, wound care, and recovery.
Post-discharge follow-up: Suture removal and wound check at 1-2 weeks. Pathology review at 2-3 weeks. Subsequent follow-up every 3 months for 2 years, every 6 months for years 3-5, and annually thereafter -- including clinical skin examination, lymph node assessment, and imaging for high-risk patients.
Recovery and Rehabilitation
Recovery after head and neck skin cancer surgery depends on the extent of excision and type of reconstruction:
After simple excision with local flap: Sutures are removed at 5-10 days. Mild swelling resolves within 1-2 weeks. Most patients return to normal activities within 1-2 weeks.
After excision with skin graft: Bolster dressing for 5-7 days ensures graft take. The donor site heals within 2 weeks. Final cosmetic appearance improves over 3-6 months.
After free flap reconstruction: Hospital stay of 7-10 days with hourly flap monitoring for the first 48-72 hours. Progressive improvement in appearance over months. Donor site recovery is typically complete within 3-4 weeks.
Scar management and surveillance: Dr. Vidhyadharan plans incisions along natural skin lines to minimise scarring. Patients with a history of skin cancer face elevated risk of additional cancers, making regular skin examinations, sun protection, and self-examination lifelong requirements.
Outcomes and Prognosis
Outcomes for head and neck skin cancer are strongly influenced by the tumour type, stage, and adequacy of surgical excision:
- Basal cell carcinoma: Cure rates exceed 99% with margin-controlled excision. Recurrence is less than 1% with Mohs-equivalent techniques versus 5-10% with standard excision.
- Squamous cell carcinoma (localised): 5-year survival exceeds 90% with wide excision and clear margins.
- Squamous cell carcinoma (with nodal metastasis): 5-year survival drops to 50-60%, underscoring the importance of sentinel node biopsy for high-risk lesions.
- Melanoma: Localised thin melanoma (less than 1 mm) exceeds 95% 5-year survival. Thick melanoma with nodal involvement has 40-60% survival. Immunotherapy has dramatically improved advanced melanoma outcomes.
The most important factors are early detection, complete excision with clear margins, and appropriate regional lymph node management. Dr. Vidhyadharan's 3,000+ surgeries and dual oncologic-reconstructive expertise ensure both adequate excision and optimal reconstruction.
Why Choose Dr. Vidhyadharan at THANC Hospital
Head and neck skin cancer surgery demands the convergence of oncologic resection expertise and reconstructive skill. Dr. Vidhyadharan Sivakumar offers this combination:
- MCh (Head & Neck Surgery), Amrita Institute of Medical Sciences -- super-specialty oncologic training covering the full spectrum of head and neck skin cancers.
- Microsurgery fellowship, Chang Gung Memorial Hospital, Taiwan -- training at one of the world's highest-volume reconstructive microsurgery centres, providing expertise in free flap reconstruction for complex facial defects.
- European Board certification (FEB-ORL HNS) -- internationally recognised competence in head and neck surgery.
- 3,000+ head and neck surgeries -- the surgical volume that published evidence consistently associates with better oncologic and reconstructive outcomes.
- Co-editor, "Comprehensive Management of Head and Neck Cancer" (Jaypee Brothers, 2021) -- contributing to the academic foundation of the specialty.
- Margin-controlled excision expertise -- ensuring complete cancer removal with maximum tissue preservation.
- Sentinel node biopsy and neck dissection -- comprehensive regional disease management for high-risk skin cancers.
THANC Hospital provides the multidisciplinary infrastructure: dermatopathology for accurate diagnosis, intraoperative frozen section margin analysis, PET-CT for staging, radiation oncology for adjuvant treatment, and a dedicated head and neck cancer centre built to manage the full spectrum of head and neck malignancies.
To schedule a consultation with Dr. Vidhyadharan Sivakumar, call +91 73059 53378 or request an appointment online.
